|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/44 | (2006.01) |
| A61P 27/02 | (2006.01) | ||
| A61K 47/10 | (2017.01) | ||
| A61K 9/08 | (2006.01) |
| (11) | Patento numeris | 3291812 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 16790066.1 |
| Europos patento paraiškos padavimo data | 2016-05-05 | |
| (97) | Europos patento paraiškos paskelbimo data | 2018-03-14 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2021-09-01 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2016/030912 |
| Data | 2016-05-05 |
| (87) | Numeris | WO 2016/179357 |
| Data | 2016-11-10 |
| (30) | Numeris | Data | Šalis |
| 201562157257 P | 2015-05-05 | US |
| (72) |
ASHTON, Paul , US
|
| (73) |
EyePoint Pharmaceuticals US, Inc. ,
400 Pleasant Street, Watertown, MA 02472,
US
|
| (54) | INJECTABLE DEPOT FORMULATIONS |
| INJECTABLE DEPOT FORMULATIONS |